It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Some features of ATS will be disabled while you continue to use an ad-blocker.
(Reuters) - Leading drugmakers plan to work together to speed up the development of an Ebola vaccine and hope to produce millions of doses for use next year.
U.S. firm Johnson & Johnson said on Wednesday that it aims to produce at least 1 million doses of its two-step vaccine next year and has already discussed collaboration with Britain's GlaxoSmithKline, which is working on a rival vaccine.
The economics of an Ebola vaccine are still unclear but drug companies with an eye on their reputations are under pressure to respond to the major international health crisis now ravaging one of the poorest corners of Africa. [Source]
originally posted by: rickymouse
Hmmm. Another vaccine I probably will have a reaction to. If everyone else takes it, I won't have to worry about getting the illness. Now if they restricted air travel from those infected areas, we wouldn't probably need this vaccine. But, of course, the drug companies are big campaign contributors. I've heard that doctors get a bonus if they talk a person into taking a vaccine if they deny it at first. I don't know how reliable this is though.
originally posted by: ValentineWiggin
In other news Liberia isn't interested in experimental drugs
Liberians Will Not Be 'Guinea Pigs'